Skip to content

Advertisement

Volume 11 Supplement 1

Challenges in malaria research

  • Poster presentation
  • Open Access

Nigerian malaria: the problems and the fight

  • 1
Malaria Journal201211 (Suppl 1) :P122

https://doi.org/10.1186/1475-2875-11-S1-P122

  • Published:

Keywords

  • Malaria
  • Malaria Parasite
  • Subtropical Region
  • Major Public Health Problem
  • Effective Vaccine

Malaria is one of the world’s top killer diseases, especially for the young children. Malaria has remained a major threat to public health and economic development in the tropical and subtropical regions of the world. Attempts to control or completely eradicate the disease have failed massively as a result of well-known resistance to drugs for the malaria parasite and to insecticides for the vector and the situation has become life-threatening. Though there is collaborative energy both at the international, national and individual level to fight the disease by developing vaccines and new drugs, no-one has produced any permanent result yet. In the field of science, education about understanding the disease has recorded a tremendous progress.

After HIV/AIDS, malaria is the second leading cause of death in Africa. It is believe that nearly 1 in every 5 deaths among kids in Africa is as a result of malaria. In my country Nigeria, malaria is a major public health problem where it accounts for more cases and deaths than any country world over. About 97% of my country’s population is at risk for malaria because of their location. It is only 3% of Nigeria’s population live in the malaria free zones. Malaria alone accounts for more than 300,000 deaths each year in Nigeria. This estimate is well above the 215,000 deaths each year from HIV/AIDS. If the above accounts for Nigeria alone how about other 29 Sub-Saharan African countries which together accounts for 90% of the world wide malaria deaths?

The vaccine, which has been promised to be ‘just round the corner’ for many years, remains elusive. It is important to ask why this is so, when effective vaccines exist for many other infectious diseases. What are the reasons for the slow rate of progress, and what has been learned from the first clinical trials of candidate malaria vaccines? What are the remaining challenges, and what strategies can be pursued to address them? The remaining major challenge is poverty. About 70% of Nigeria population lives in poverty. Should any permanent remedy be found any time soon, these Sub-Saharan African countries like Nigeria should be the starting point in the fight to eliminating malaria!

Authors’ Affiliations

(1)
King Emerson Medical Foundation, Lagos, Nigeria, 23401

Copyright

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement